Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
261 studies found for:    Syncope
Show Display Options
Rank Status Study
1 Unknown  Eastbourne Syncope Assessment Study II
Condition: Syncope
Interventions: Device: Sleuth Implantable Loop Recorder;   Other: Other
2 Unknown  Closed Loop Stimulation for Neuromediated Syncope (SPAIN Study)
Condition: Syncope, Vasovagal
Intervention: Device: Pacemaker with Closed Loop Stimulation (CLS sensor)
3 Completed Syncope Patient Evaluation in the Emergency Department
Condition: (Near) Syncope
4 Recruiting EEG Characteristics in Youth POTS and/or Syncope
Conditions: Syncope;   Postural Tachycardia Syndrome;   Orthostatic Intolerance
Intervention: Device: Abdominal and lower extremity compression
5 Completed Prevention of Syncope by Cardiac Pacing in Patients With Bifascicular Block
Conditions: Bifascicular Block;   Syncope
Intervention: Device: DDD60 (INSIGNIA® pacing systems Guidant (Boston Scientific)
6 Completed Validation of the San Francisco Syncope Rule
Conditions: Syncope;   Near Syncope
Intervention: Procedure: Application of the San Francisco Syncope Rule
7 Completed Guideline-based Pacing Therapy for Reflex Syncope
Condition: Syncope
8 Recruiting Assessment of Metoprolol in the Prevention of Vasovagal Syncope in Aging Subjects
Condition: Vasovagal Syncope
Interventions: Drug: Metoprolol;   Drug: Matching Placebo
9 Recruiting Assessment of Midodrine in the Prevention of Vasovagal Syncope: The Prevention of Syncope Trial IV
Condition: Vasovagal Syncope
Interventions: Drug: midodrine hydrochloride;   Drug: matching placebo
10 Completed Stop Vasodepressor Drugs in Reflex Syncope
Condition: Hypotensive Syncope
Interventions: Drug: Vasoactive drug therapies;   Other: Stop/reduce vasoactive drugs
11 Recruiting Syncope Prediction Study
Condition: Vasovagal Syncope
12 Completed Effect of Closed Loop Pacemaker Treatment on Recurrent Vasovagal Syncope
Condition: Vasovagal Syncope
Interventions: Device: Pacemaker treatment, pacemaker programmed as active = CLS;   Device: Pacemaker, programmed as passive = VVI 30 beats per minute (bpm)
13 Active, not recruiting Syncope: Pacing or Recording in the Later Years
Conditions: Syncope;   Heart Block;   Conduction Disorder of the Heart
Interventions: Procedure: pacemaker;   Procedure: implantable loop recorder
14 Completed Clinical Trial for the Prevention of Vasovagal Syncope
Condition: Syncope, Vasovagal, Neurally-Mediated
Intervention: Drug: fludrocortisone acetate
15 Completed Prevalence of Pulmonary Embolism in Patients With Syncope
Conditions: Syncope;   Pulmonary Embolism
Intervention: Other: Lung CT or V/Q scanning in patients with a high pre-test clinical probability of PE and/or a positive D-dimer
16 Completed Influence of Yoga in Patients With Neurocardiogenic Syncope
Condition: Syncope, Vasovagal
Intervention: Other: Yoga
17 Withdrawn Autonomous Syncope Onset Prediction and Prevention
Condition: Syncope
Intervention: Device: tilt table Erigo®
18 Completed Cardioneuroablation for Neurocardiogenic Syncope
Conditions: Neurocardiogenic Syncope;   Vasovagal Syncope
Interventions: Procedure: Cardioneuroablation;   Device: Biosense Webster Navistar ThermoCool Diagnostic/Ablation Deflectable Tip Catheter
19 Recruiting Comparison Between Standard and Ultrasound Integrated Approach for Risk Stratification of Syncope in the Emergency Department
Condition: Syncope
20 Recruiting A Proof of Principal Study of Atomoxetine for the Prevention of Vasovagal Syncope
Condition: Syncope, Vasovagal
Interventions: Drug: Atomoxetine;   Drug: Matching Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years